SOLICITATION NOTICE
66 -- MicroSelectron HDR V2 (18-ch) S/N 31253 hardware and TCS Upgrade to MicroSelectron Digital-18
- Notice Date
- 7/27/2012
- Notice Type
- Presolicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
- ZIP Code
- 20852
- Solicitation Number
- NCI-120124-TG
- Archive Date
- 8/25/2012
- Point of Contact
- Terry Galloway, Phone: 301-402-4509, Caren N Rasmussen, Phone: (301) 402-4509
- E-Mail Address
-
gallowaytl@mail.nih.gov, cr214i@nih.gov
(gallowaytl@mail.nih.gov, cr214i@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Contracting Office Address Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd. EPS Room 6074, Rockville, MD, 20852, UNITED STATES Description The National Cancer Institute (NCI), Center for Cancer Research (CCR), Radiation Oncology Branch (ROB) plans to procure on a sole source basis MicroSelectron HDR V2 (18-ch) S/N 31253 hardware and TCS Upgrade to MicroSelectron Digital-18 from Nucletron Corporation, 8671 Robert Fulton Drive, Columbia, MD 21046 This acquisition will be processed in accordance with simplified acquisition procedures as stated in FAR Part 13.106-1(b)(1). The North American Industry Classification System code is 334516 and the business size standard is 500 Employees. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. Delivery will be made ninety (90) days after award. It has been determined there are no opportunities to acquire green products or services for this procurement. The Radiation Oncology Branch of the CCR treats cancer patients with radiation according to approved clinical protocols. ROB has current as well as planned clinical protocols involving the use of High Dose-Rate (HDR) brachytherapy via remote afterloading to treat a variety of cancers. ROB currently treats cancer of the cervix using the Nucletron MicroSelectron HDR Afterloader, which the department acquired 10 years ago. Future protocols will involve treatment of breast and prostate cancer with this device. The technology of the current device is obsolescent and an upgrade to a fully digital system is required in order to maintain a state-of-the-art treatment modality which integrates fully with the Nucletron Oncentra-BPS treatment planning system acquired in FY-09. This upgrade involves replacing components in the afterloader proper, as well as replacing the controller and upgrading the controlling software. This upgrade also provides the framework for full implementation of DICOM-RT import and export of all treatment planning and treatment delivery data for research purposes. Additionally, the upgrade provides for the modeling of the geometry of all current Nucletron gynecological applicators, including the CT/MR Vaginal Cylinder applicator and the CT/MR Tandem/Ovoid applicator specifically used by ROB for clinical research. MicroSelectron HDR v2 remote afterloader, serial # 31253. This unit is used for the delivery of radiation interstitially via a small radioactive source (brachytherapy) accurately positioned to produce a highly conformal dose distribution within and surrounding the target volume. The current v2 system has reached the end of its operational life and has become obsolete. The replacement is the MicroSelectron Digital. This retains the external framework and shielding of the original unit, but replaces internal parts to provide superior digital positioning and stepping of the source. Because only internal parts are replaced, an upgrade is the cost effective path to obtain new unit functionality. In addition to the unit itself, the Treatment Control Unit, or TCU, is also replaced, providing a much more reliable communications pathway with superior treatment control and positioning software. The TCU is also more thoroughly integrated with the Nucletron Oncentra BPS treatment planning system. This upgrade adds DICOM-RT import/export functionality to the treatment planning system. DICOM-RT is the common format for storing and communicating image sets and related information used in radiation therapy. This is not possible with the existing.v2 system. Additionally, a unique extension termed Applicator Modeling is provided for the new framework. Under this paradigm, the geometry of all Nucletron gynecological applicators is stored in a library and loaded as that applicator is used in the treatment plan. This reduces treatment planning time considerably and increases the accuracy of source localization. The Nucletron Corporation is the sole manufacturer and distributor of this device. They are the developer and sole source of the required upgrade. The manufacture, distribution and operation of this device is governed by the U.S. Nuclear Regulatory Commission (USNRC). This device is operated at NIH under the terms of a Broad License which NIH has been granted by the USNRC. The USNRC requires that ALL maintenance (including upgrades) be performed by factory trained personnel under factory supervision. This is based on national security concerns and is aimed at preventing theft of nuclear materials and their possible transfer to terrorist organizations for nefarious purposes. Failure to comply with this provision would be a major license violation and would result in the loss or suspension of the Broad License, heavy fine and/or prison term. Therefore, Nucletron is the only source permitted to provide this service and perform this upgrade. This notice is not a request for competitive quotation. However, if any interested party believes it can meet the above requirement, it may submit a statement of capabilities. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform the requirement. Capability statements must be received in the contracting office by 11:00 AM EST, on August 10, 2012. For further information, please contact Terry Galloway, Contract Specialist via electronic mail at gallowaytl@mail.nih.gov. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. No faxed or emailed capability statements will be accepted. In order to receive an award, contractors must be registered and have valid certification in the Central Contractor Registration (CCR) and the Online Representations and Certifications Applications (ORCA). Reference: NCI-120124-TG on all correspondence.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/NCI-120124-TG/listing.html)
- Record
- SN02819042-W 20120729/120728001138-b3a81cdee35212f6eb0142295609be7e (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |